Clinical Trial - Trial jRCT2031220674
Access comprehensive clinical trial information for jRCT2031220674 through Pure Global AI's free database. This phase not specified trial is sponsored by Astellas Pharma Global Development Inc. and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031220674
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031220674
Untitled Trial
A Phase 2 Open label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Study Focus
Interventional
Sponsor & Location
Astellas Pharma Global Development Inc.
United States of America;Argentina;Australia;Belgium;Canada;Chile;Czech;Denmark;Finland;France;Georg
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm of prostate
Hyperplasia of prostate
Disorder of prostate, unspecified
Other disorders of prostate
Carcinoma in situ: Prostate
Data Source
Japan Registry Clinical Trial
jRCT2031220674
Non-Device Trial